Correlation Engine 2.0
Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Cognitive impairment is currently considered a core feature of schizophrenia (SZ) and is gaining attention as a fundamental therapeutic target. Standard treatment for SZ involves the use of antipsychotics that are successfully used to control positive symptoms and disorganized behaviour. However, it is still unclear whether they are effective on social cognition (SC) impairment. Furthermore, different medications are currently being studied to improve SC in patients with SZ. A literature search on this topic was conducted using the PubMed database. All kinds of publications (i.e., reviews, original contributions and case reports) written in English and published in the last 15 years were included. The aim of our literature review is to draw a picture of the current state of the pharmacological treatment of SC impairment in SZ.

Citation

Cecilia Riccardi, Cristiana Montemagni, Elisa Del Favero, Silvio Bellino, Claudio Brasso, Paola Rocca. Pharmacological Treatment for Social Cognition: Current Evidence. International journal of molecular sciences. 2021 Jul 12;22(14)

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 34299076

View Full Text